Statin May Help Lower Risk of Prostate Cancer

Researchers over at Mayo Clinic have announced that the use of statin (a type of drug that lowers cholesterol) may also reduce the risk of prostate cancer. The Minnesota-based team utilized data from 2,427 men with ages between 40 and 79, and has enrolled them in the Olmsted County Study of Urinary Symptoms and Health Status among Men.

The 19-year-long study had the patients underwent a detailed clinic exam, including prostate specific antigen (PSA) measurements. These PSA levels are then measures every year.

According to the data, only six percent of those who took statin were diagnosed with prostate cancer, while those who did not were three times more likely to develop prostate cancer.

Despite the positive news, scientists however think that the result can be caused by the drug’s anti-inflammatory quality.